Bioventus launches SUPARTZ FX for knee OA: 3 key notes

Bioventus launched SUPARTZ FX, a non-surgical, non-pharmacologic therapy for knee osteoarthritis.

Advertisement

Here are three key notes:

 

1. SUPARTZ FX has an expanded label allowing for repeat injection cycles to help knee osteoarthritis patients manage pain and remain active.

 

2. SUPARTZ FX aims to help restore the body’s natural HA production. The therapy is available now.

 

3. Bioventus is an orthobiologics company that focuses on delivering cost-effective products.

 

More articles on devices:
Titanium vs. PEEK: Is there a difference in wear debris for spinal implants?
LDR’s ROI-C Cervical Cage receives expanded indication approval: 4 points
Analysts: Smith & Nephew ripe for acquisition — 7 key takeaways

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.